These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 1678066)
1. Beta 2-agonists and New Zealand asthma mortality. Burgess C; Crane J; Pearce N; Beasley R Lancet; 1991 Apr; 337(8747):982-3. PubMed ID: 1678066 [No Abstract] [Full Text] [Related]
2. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992. Lanes SF; Birmann B; Raiford D; Walker AM J Clin Epidemiol; 1997 Mar; 50(3):321-8. PubMed ID: 9120532 [TBL] [Abstract][Full Text] [Related]
3. Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic. Beasley R; Pearce N; Crane J; Burgess C Int Arch Allergy Immunol; 1995; 107(1-3):325-7. PubMed ID: 7613161 [TBL] [Abstract][Full Text] [Related]
4. Fenoterol and asthma deaths. Grant IW Thorax; 1998 Jan; 53(1):77. PubMed ID: 9577529 [No Abstract] [Full Text] [Related]
5. The saga of the New Zealand asthma mortality epidemic. N Z Med J; 1995 Mar; 108(995):91. PubMed ID: 7661939 [No Abstract] [Full Text] [Related]
9. End of the New Zealand asthma mortality epidemic. Pearce N; Beasley R; Crane J; Burgess C; Jackson R Lancet; 1995 Jan; 345(8941):41-4. PubMed ID: 7799709 [TBL] [Abstract][Full Text] [Related]
10. Asthma and the beta agonist debate. Crane J; Pearce N; Burgess C; Beasley R Thorax; 1995 Sep; 50 Suppl 1(Suppl 1):S5-10. PubMed ID: 7570465 [No Abstract] [Full Text] [Related]
11. Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic. Suissa S; Ernst P J Clin Epidemiol; 1997 Oct; 50(10):1079-88. PubMed ID: 9368515 [TBL] [Abstract][Full Text] [Related]
12. The use of beta agonists and the risk of death and near death from asthma. Pearce N J Clin Epidemiol; 2009 Jun; 62(6):582-7. PubMed ID: 19422997 [No Abstract] [Full Text] [Related]
13. Re: "Confounding by indication and channeling over time: the risks of beta2-agonists". Pearce N; Beasley R; Crane J; Burgess C Am J Epidemiol; 1997 Nov; 146(10):885-7. PubMed ID: 9384211 [No Abstract] [Full Text] [Related]
14. Beta agonists and asthma mortality: déjà vu. Pearce N; Crane J; Burgess C; Jackson R; Beasley R Clin Exp Allergy; 1991 Jul; 21(4):401-10. PubMed ID: 1680532 [No Abstract] [Full Text] [Related]
15. Asthma therapy and mortality. Ford RM Med J Aust; 1991 Mar; 154(6):427-8. PubMed ID: 1672035 [No Abstract] [Full Text] [Related]
16. Asthma. Bronchodilators: new developments. Tattersfield AE Br Med Bull; 1992 Jan; 48(1):190-204. PubMed ID: 1352168 [TBL] [Abstract][Full Text] [Related]
17. [Increased asthma fatality in chronic administration of beta agonists?]. Geisler LS Dtsch Med Wochenschr; 1993 Feb; 118(6):206-7. PubMed ID: 8094666 [No Abstract] [Full Text] [Related]
18. Beta-agonists and death from asthma. Pearce N; Crane J; Burgess C; Beasley R; Jackson R N Engl J Med; 1992 Jul; 327(5):355-7. PubMed ID: 1352379 [No Abstract] [Full Text] [Related]
20. The proper role of beta 2-adrenergic agonists in the treatment of children with asthma. Furukawa CT; Kemp JP; Simons FE; Tinkelman DG Pediatrics; 1992 Oct; 90(4):639-40. PubMed ID: 1357623 [No Abstract] [Full Text] [Related] [Next] [New Search]